Three-year Effectiveness in Patients with JIA Initiating Abatacept: Results from the PRCSG/PRINTO JIA Real-World Registry

被引：0

作者：

Ruperto, Nicolino ^{[1
,2
]}

Brunner, Hermine ^{[3
]}

Tzaribachev, Nikolay ^{[4
]}

Orban, Ilonka ^{[5
]}

Stanevica, Valda ^{[6
]}

del Rio, Ana Quintero ^{[7
]}

Quartier, Pierre ^{[8
]}

Huber, Adam ^{[9
]}

Kietz, Dan ^{[10
]}

Dare, Jason ^{[11
]}

Kingsbury, Daniel ^{[12
]}

Graham, T. Brent ^{[13
]}

Foeldvari, Ivan ^{[14
]}

Patel, Julisa ^{[15
]}

Dominique, Alyssa ^{[16
]}

Dong, Lixian ^{[16
]}

Kou, Tzuyung Douglas ^{[16
]}

Wong, Robert ^{[17
]}

Martini, Alberto ^{[18
]}

Lovell, Daniel ^{[19
]}

机构：

[1] IRCCS Ist Giannina Gaslini, Genoa, Italy

[2] PRINTO, Clin Pediat & Reumatol, Genoa, Italy

[3] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA

[4] PRI Res, Bad Bramstedt, Germany

[5] Natl Inst Rheumatism & Physiotherapy, Budapest, Hungary

[6] Riga Stradins Univ, Riga, Latvia

[7] Dr Ramon Ruiz Arnau Univ Hosp, Bayamon, PR USA

[8] Necker Enfants Malades Univ Hosp, AP HP, Paris, France

[9] Dalhousie Univ, Halifax, NS, Canada

[10] Childrens Hosp Pittsburgh, Pittsburg, KS USA

[11] Univ Arkansas Med Sci, Little Rock, AR 72205 USA

[12] Randall Childrens Hosp Legacy Emanuel, Portland, OR USA

[13] Vanderbilt Univ, Med Ctr, Nashville, TN USA

[14] Hamburg Ctr Pediat & Adolescent Rheumatol, Hamburg, Germany

[15] Augusta Univ, Childrens Hosp Georgia, Med Ctr, Augusta, GA USA

[16] Bristol Myers Squibb, Princeton, NJ USA

[17] Bristol Myers Squibb, Basking Ridge, NJ USA

[18] Paediat Rheumatol Int Trials Org PRINTO, Genoa, Italy

[19] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0247

引用

页码：500 / 502

页数：3

共 50 条

[31] Subcutaneous or Intravenous Abatacept Monotherapy in Pediatric Patients with Polyarticular-Course JIA: Results from Two Phase III Trials
Ruperto, Nicolino
Lovell, Daniel J.
Bohnsack, John
Breedt, Johannes
Fischbach, Michel
Lutz, Thomas
Minden, Kirsten
Miravar, Tatiana
Ally, Mahmood M. T. M.
Rubio-Perez, Nadina
Gervais, Elisabeth
van Zyl, Riana
Wong, Robert
Nys, Marleen
Martini, Alberto
Brunner, Hermine
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[32] Three-Year Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide as a Switch Strategy in the Real World
de Gea-Grela, Alejandro
Mican, Rafael
de Miguel, Rosa
Serrano, Lucia
Marcelo, Cristina
Montes, Maria Luisa
Ramos-Ruperto, Luis
Busca, Carmen
Arcos-Rueda, Maria del Mar
Montejano, Rocio
Arribas, Jose Ramon
Gonzalez-Garcia, Juan
Bernardino, Jose Ignacio
Martin-Carbonero, Luz
OPEN FORUM INFECTIOUS DISEASES, 2025, 12 (03):
[33] Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Data from the PROSE Registry
Simpson, E. L.
Havenith, R.
Lockshin, B.
Lee, L. W.
Chen, Z.
Daoud, M.
Korotzer, A.
ALLERGOLOGIE, 2023, 46 (08) : 533 - 534
[34] Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients With Atopic Dermatitis: 2-Year Data From the PROSE Registry
Simpson, Eric L.
Lockshin, Benjamin
Lee, Lara Wine
Chen, Zhen
Daoud, Moataz
Korotzer, Andrew
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB81 - AB81
[35] Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registry
Iborra, M.
Beltran, B.
Fernandez-Clotet, A.
Gutierrez, A.
Antolin, B.
Huguet, J. M.
De Francisco, R.
Merino, O.
Carpio, D.
Garcia-Lopez, S.
Mesonero, F.
Navarro, P.
Ferreiro-Iglesias, R.
Carbajo, A. Y.
Rivero, M.
Gisbert, J. P.
Pinero-Perez, M. C.
Monfort, D.
Bujanda, L.
Garcia-Sepulcre, M. F.
Martin-Cardona, A.
Canete, F.
Taxonera, C.
Domenech, E.
Nos, P.
Sierra-Ausin, M.
Ferrer-Rosique, J. A.
Martin-Arranz, M. D.
Gonzalez-Munoza, C.
Mancenido, N.
Rodriguez-Lago, I.
Benitez, J. M.
Fores-Bosch, A.
Navarro-Llavat, M.
Calafat, M.
Madrigal-Dominguez, R. E.
Ramos, L.
Arroyo, M.
Busquets, D.
Lorente, R.
Sainz-Arnau, E.
Hernandez-Camba, A.
Morales-Alvarado, V. J.
Paredes, J. M.
Van Domselaar, M.
Hervas, D.
Canada-Martinez, A.
Castro-Poceiro, J.
Cameo-Lorenzo, J.
Fernandez-Salazar, L.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (03) : 278 - 288
[36] ABATACEPT RETENTION RATES AND PROGNOSTIC FACTORS OF RETENTION IN PATIENTS WITH RHEUMATOID ARTHRITIS: 2-YEAR RESULTS FROM THE REAL-WORLD ACTION STUDY
Alten, R.
Lorenz, H-M.
Mariette, X.
Nuesslein, H.
Galeazzi, M.
Navarro, F.
Chartier, M.
Elbez, Y.
Rauch, C.
Le Bars, M.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 577 - 578
[37] Real-world characteristics and treatment persistence in patients initiating CLES: Results from a cohort of 1290 patients in USA
Pagan, Fernando
Rodriguez-Cruz, Ramon
Soileau, Michael
Alobaidi, Ali
Kandukuri, Prasanna
Hayes, Oscar
Jalundhwala, Yash
Ladhani, Omar
Siddiqui, Mustafa
NEUROLOGY, 2021, 96 (15)
[38] REAL-WORLD CHARACTERISTICS OF PATIENTS INITIATING ORAL TREPROSTINIL IN THE ADAPT REGISTRY: INTERIM BASELINE CHARACTERISTICS
Sahay, Sandeep
Ravichandran, Ashwin
Mogri, Mohammed
Parikh, Kishan
Gordon, Kathryn
Broderick, Meredith
Turpin, Bucky
Chen, Luming
Nelsen, Andrew
CHEST, 2019, 156 (04) : 1180A - 1181A
[39] Real-world cost-effectiveness of infliximab, etanercept and adalimumab in rheumatoid arthritis patients: results of the CREATE registry
Cardenas, M.
de la Fuente, S.
Font, P.
Castro-Villegas, M. C.
Romero-Gomez, M.
Ruiz-Vilchez, D.
Calvo-Gutierez, J.
Escudero-Contreras, A.
Casado, M. A.
Del Prado, J. R.
Collantes-Estevez, E.
RHEUMATOLOGY INTERNATIONAL, 2016, 36 (02) : 231 - 241
[40] Real-world cost-effectiveness of infliximab, etanercept and adalimumab in rheumatoid arthritis patients: results of the CREATE registry
M. Cárdenas
S. de la Fuente
P. Font
M. C. Castro-Villegas
M. Romero-Gómez
D. Ruiz-Vílchez
J. Calvo-Gutiérez
A. Escudero-Contreras
M. A. Casado
J. R. Del Prado
E. Collantes-Estévez
Rheumatology International, 2016, 36 : 231 - 241

← 1 2 3 4 5 →